Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Baird Analyst Maintains Neutral Rating on MasTec with Raised Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
FLO stock news
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Andrew Wittmann, an analyst at Baird, has decided to maintain a Neutral rating on MasTec (NYSE: MTZ) while raising the price target to $89, up from $70. This adjustment is a reflection of Wittmann’s assessment of the company’s potential performance. Wittmann, a respected Wall Street Analyst focusing on the Services sector, closely follows MasTec and other related stocks. For further insights into Baird’s research coverage and analyst insights, please visit their official website.

[bs_slider_forecast ticker=”MTZ”]

MasTec, Inc. (MTZ) Stock Surges 12.44% on March 4, 2024: Potential for Growth and Success in the Market

On March 4, 2024, MasTec, Inc. (MTZ) showed impressive stock performance, with the price of its shares increasing by $9.39 since the market last closed. This represents a significant 12.44% rise in value, with the stock closing at $84.85. Additionally, in pre-market trading, MTZ saw a further increase of $0.15 in its stock price. MTZ is currently trading in the middle of its 52-week range and is above its 200-day simple moving average. This indicates that the stock has been performing steadily and is showing positive momentum in its price movement. The increase in MTZ’s stock price can be attributed to various factors, such as positive earnings reports, strong financial performance, or favorable market conditions. Overall, MTZ’s stock performance on March 4, 2024, demonstrates its potential for growth and success in the market. Investors may consider adding MTZ to their portfolio for potential long-term gains.

MasTec, Inc. Reports Mixed Financial Results for 2023, Investors Await Future Performance

On March 4, 2024, MasTec, Inc. (MTZ) saw mixed performances in its stock as the company reported its financial results for the past year and the fourth quarter. MasTec reported total revenue of $11.99 billion for the past year, representing a 22.68% increase compared to the previous year. The total revenue remained flat at $3.28 billion for the fourth quarter. MasTec reported a net loss of $49.95 million for the past year, a significant decrease of 249.75% compared to the previous year. The net income for the fourth quarter was $753.00 thousand, a decrease of 94.73% compared to the previous quarter. Earnings per share (EPS) for MasTec were also impacted, with a reported EPS of -$0.64 for the past year, a decrease of 254.97% compared to the previous year. The EPS for the fourth quarter remained flat at $0.01. Investors and analysts will be closely monitoring MasTec’s future financial performance to see if the company can improve its profitability and EPS in the coming quarters.

Tags: MTZ
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances

Analyst Reiterates Buy Rating on Life Time Group Holdings with Revised Price Target

MO stock news

Financial Analyst Reaffirms Positive Outlook on Metropolitan Bank Holding with Revised Price Target

CTVA stock news

Entegris Provides Earnings Guidance for Q1 FY 2024

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com